VoxelCloud
- Industry
- Medical Equipment Manufacturing
- Founded Year
- 2016
- Headquarters
- Los Angeles, CA, USA
- Employee Count
- 35
Key People
- Xiaowei Ding - Founder and CEO
- Demetri Terzopoulos - Co-Founder and Chief Scientist
- Aarthi Narain - Chief Product Officer
- Beichen Su - Chief Operating Officer
Assessment
- Team
-
Aspect: Multiple successful MedTech entrepreneurs
Summary: The leadership team comprises experienced professionals with backgrounds in medical technology and artificial intelligence.
The presence of multiple successful MedTech entrepreneurs in the leadership team enhances the company's capability to navigate the complex medical device industry, fostering innovation and strategic growth.
- Clinical Need
-
Aspect: Very Strong
Summary: VoxelCloud addresses critical needs in medical imaging diagnostics, including lung cancer, retinal diseases, and coronary heart disease.
By targeting major health issues with high morbidity and mortality rates, VoxelCloud's solutions meet a pressing clinical need, potentially improving patient outcomes and reducing healthcare costs.
- Competition
-
Aspect: Somewhat crowded
Summary: The AI-assisted medical imaging market is competitive, with several players offering similar solutions.
The presence of multiple competitors in the AI medical imaging space necessitates unique value propositions and superior performance to capture and maintain market share.
- Technical Challenge
-
Aspect: Moderate
Summary: Developing accurate AI algorithms for medical imaging is complex but achievable with current technology.
The development of AI solutions for medical imaging involves intricate algorithm design and validation, but advancements in AI and computing power make these challenges manageable.
- Patent
-
Aspect: Applied
Summary: VoxelCloud has applied for patents to protect its proprietary technologies.
Patents provide legal protection for innovations, preventing competitors from replicating unique technologies and offering a competitive advantage in the market.
- Financing
-
Aspect: Well-funded
Summary: VoxelCloud has raised significant funding from reputable investors, totaling $78.5 million.
Adequate financing enables the company to invest in research, development, and commercialization efforts, facilitating growth and innovation.
- Regulatory
-
Aspect: 510k/PMA
Summary: VoxelCloud has obtained FDA and CE approvals for its CT Image Analysis product line.
Achieving regulatory clearances is crucial for market entry and demonstrates compliance with safety and efficacy standards, building trust with healthcare providers and patients.
Opportunity Rollup
- Odds of Success
- 3.6
- Peak Market Share
- 4.6
- Segment CAGR
- 2.9%
- Market Segment
- Diagnostic Imaging
- Market Sub Segment
- AI-assisted Medical Imaging
| Year Post Launch | Market Penetration (%) |
|---|---|
| 1 | 0.23 |
| 2 | 0.69 |
| 3 | 1.61 |
| 4 | 3.22 |
| 5 | 4.60 |
Key Takeaway
VoxelCloud's strong leadership and innovative AI solutions position it well in the growing AI-assisted medical imaging market, despite competitive and regulatory challenges.